Amelioration of hyperlipidemia and atherosclerosis risk index by Moringa oleifera leaf extract
Life Science Journal - Acta Zhengzhou University Overseas Edition • 2019
Publication Information
Authors
I Gheith, A El-Mahmoudy
Keywords
Moringa oleifera; hyperlipidemia; atherosclerosis; phytomedicine
Journal
Life Science Journal - Acta Zhengzhou University Overseas Edition
Publisher
Marsland Press / Zhengzhou University
Volume
16
Issue
2
Pages
10-17
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Hyperlipidemia and atherosclerosis are among major health risk concerns. The aim of the present study
was to evaluate the possible improving potentials of Moringa oleifera extract (MOE), in hydroethanol 30%, on lipid
metabolic profile in hyperlipidemic rat model. Rats were rendered hyperlipidemic by 6-week supplementation of
high-fat diet ad libitum. Rats were assigned into six groups; with different treatments (group-1 received normal diet
and kept as normal control; group-2 were fed high-fat (cholesterol 2% + coconut oil 2%) diet for 6 weeks and kept
as diseased control; group-3 were kept on high-fat diet but received ezetimibe (1 mg/Kg, orally, daily) and kept as
standard; while rats of groups-4, -5 and -6 were kept on high-fat diet and received MOE at doses of 200, 400 and
600 mg/Kg, orally, daily, and kept as treated groups. Blood samples for serum were taken for clinicochemical
analysis on the days 21 (3 weeks) and 42 (6 weeks) of the experiment and tissue specimens from the aorta were
taken for histopathology. MOE extract significantly (P
was to evaluate the possible improving potentials of Moringa oleifera extract (MOE), in hydroethanol 30%, on lipid
metabolic profile in hyperlipidemic rat model. Rats were rendered hyperlipidemic by 6-week supplementation of
high-fat diet ad libitum. Rats were assigned into six groups; with different treatments (group-1 received normal diet
and kept as normal control; group-2 were fed high-fat (cholesterol 2% + coconut oil 2%) diet for 6 weeks and kept
as diseased control; group-3 were kept on high-fat diet but received ezetimibe (1 mg/Kg, orally, daily) and kept as
standard; while rats of groups-4, -5 and -6 were kept on high-fat diet and received MOE at doses of 200, 400 and
600 mg/Kg, orally, daily, and kept as treated groups. Blood samples for serum were taken for clinicochemical
analysis on the days 21 (3 weeks) and 42 (6 weeks) of the experiment and tissue specimens from the aorta were
taken for histopathology. MOE extract significantly (P
Staff Members - Benha University